For the quarter ending 2025-09-30, BCRX has $446,424K in assets. $834,313K in debts. $84,078K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | 2024-12-31 | |
|---|---|---|---|---|
| Cash and cash equivalents | 84,078 | 88,033 | 104,713 | |
| Restricted cash | 579 | 492 | 210 | |
| Short-term investments | 128,795 | 172,005 | 216,137 | |
| Trade receivables | 91,325 | 91,177 | 79,069 | |
| Inventory, net | 5,232 | 5,044 | 8,087 | |
| Prepaid expenses and other current assets | 16,502 | 12,541 | 13,752 | |
| Current assets held for sale-Disposal Group Heldforsale Not Discontinued Operations | 29,173 | 29,170 | - | |
| Total current assets | 355,684 | 398,462 | 421,968 | |
| Long-term inventory, net | 23,390 | 22,205 | 23,187 | |
| Property and equipment, net | 8,396 | 8,457 | 7,777 | |
| Long-term investments | 39,669 | 10,101 | 20,323 | |
| Right of use assets | 10,840 | 11,546 | 12,008 | |
| Other assets | 4,387 | 3,592 | 5,157 | |
| Non-current assets held for sale-Disposal Group Heldforsale Not Discontinued Operations | 4,058 | 2,825 | - | |
| Total assets | 446,424 | 457,188 | 490,420 | |
| Accounts payable | 5,567 | 8,589 | 11,644 | |
| Accrued expenses | 118,778 | 107,114 | 113,292 | |
| Operating lease liabilities | 348 | 392 | 937 | |
| Finance lease liabilities | 1,435 | 1,616 | 1,835 | |
| Royalty financing obligations | 37,686 | 35,741 | 32,676 | |
| Current liabilities held for sale-Disposal Group Heldforsale Not Discontinued Operations | 26,423 | 23,708 | - | |
| Total current liabilities | 190,237 | 177,160 | 160,384 | |
| Operating lease liabilities | 8,425 | 8,489 | 7,924 | |
| Finance lease liabilities | 1,742 | 2,043 | 2,124 | |
| Royalty financing obligations | 439,107 | 447,842 | 481,053 | |
| Secured term loan | 194,366 | 242,794 | 314,869 | |
| Non-current liabilities held for sale-Disposal Group Heldforsale Not Discontinued Operations | 436 | 454 | - | |
| Total liabilities | 834,313 | 878,782 | 966,354 | |
| Common stock, 0.01 par value shares authorized - 450,000 shares issued and outstanding 210,522 at september30, 2025 and 208,543 at december31, 2024 | 2,105 | 2,099 | 2,085 | |
| Additional paid-in capital | 1,360,890 | 1,339,584 | 1,291,100 | |
| Accumulated other comprehensive income | 1,140 | 1,646 | 921 | |
| Accumulated deficit | -1,752,024 | -1,764,923 | -1,770,040 | |
| Total stockholders deficit | -387,889 | -421,594 | -475,934 | |
| Total liabilities and stockholders deficit | 446,424 | 457,188 | 490,420 | |
BIOCRYST PHARMACEUTICALS INC (BCRX)
BIOCRYST PHARMACEUTICALS INC (BCRX)